Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerability of Tideglusib in Mild to Moderate Alzheimer's Disease
NCT00948259Phase 2Completed
- Sponsor
- Noscira S.A.
- Start
- Dec 2008
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tideglusib in Alzheimer's disease (AD), sponsored by Noscira S.A.. Started Dec 2008; status: completed.
02
Drugs
tideglusib
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00948259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00948259.